• Publications
  • January 2016
  • 30 minutes

ReFlections Volume 37, January 2016

  • Dr. Philip Smalley
  • Hilary Henly
Skip to Authors and Experts
Critical Illness ReFlections
In Brief
Learn more about the intricacies of Critical Illness (CI) product development and review cervical cancer.

It was a pleasure to see so many of our friends and colleagues at the recent American Academy of Insurance Medicine (AAIM) Triennial meeting in Colorado Springs. Hopefully, everyone found it as educational and inspirational as we did.

This edition features an article by Dr. Philip Smalley, Senior Vice President and Global Chief Medical Officer for RGA International Corporation, which discusses the history and intricacies of developing Critical Illness (CI) products. It also features an article by Hilary Henly, Head of Underwriting (Ireland) and Director of Divisional Underwriting Research, RGA Reinsurance Company, and one of ReFlections’ frequent contributors. Her article provides a comprehensive review and update on the medical status of cervical cancer. We trust both articles will provide the reader with practical and usable information.

We are also continuing our new and popular section, ReCite, in which we provide links to recent and relevant journal articles we believe will be of interest to medical directors and underwriters. Lastly, we include an update of recent developments at the Longer Life Foundation. Eight research grants were made for 2015 – 2016, funding innovative projects on topics of interest to all in the insurance industry.

Hospital ward
Critical Illness Insurance: A Medical Perspective
Graphic representation of cervical cancer cells
Cervical Cancer Update 2016
A physician analyzing a case
Explore the Magazine

More Like This...

Meet the Authors & Experts

Dr. Philip Smalley
Senior Vice President (ret.), Global Chief Medical Officer, RGA
Hilary Henly
Hilary Henly
Global Medical Researcher, Strategic Research